Ara
Toplam kayıt 1, listelenen: 1-1
Dasatinib-induced severe hemorrhagic colitis in chronic myeloid leukemia
(Akademi Doktorlar Yayınevi, 2016)
Dear Editor, Dasatinib is an orally administered, potent, secondline tyrosine kinase inhibitor which is used for treating imatinib resistant or intolerant chronic myeloid leukemia (CML) and Philadelphia chromosome-positive ...